866052009: Mixed ductal-neuroendocrine carcinoma of pancreas (disorder)

• SNOMED CT Concept\Clinical finding (finding)\...
• \Viscus structure finding (finding)\Abdominal organ finding\...
• \Finding of pancreas\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of pancreas\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Mass of digestive structure\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Mass of digestive structure\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Finding of pancreas\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Finding of pancreas\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Disorder of digestive system (disorder)\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Digestive system finding (finding)\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Mass of retroperitoneal structure (finding)\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Finding of pancreas\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Finding of pancreas\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Neoplasm of endocrine system (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of digestive structure\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of digestive structure\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Mass of body structure\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neuroendocrine neoplasm (disorder)\Neuroendocrine neoplasm, malignant\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of endocrine system (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Neuroendocrine neoplasm, malignant\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant epithelial neoplasm (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of endocrine system\Neoplasm of endocrine system (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of endocrine system\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of digestive system (disorder)\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of body system\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas
• \Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.\Mixed ductal-neuroendocrine carcinoma of pancreas

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3957069012	Mixed ductal-neuroendocrine carcinoma of pancreas	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3957070013	Mixed ductal-neuroendocrine carcinoma of pancreas (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7682051000241112	carcinome mixte canalaire et neuroendocrine du pancréas	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

This concept is not in any reference sets

Back to Start